Acciones Sawai Pharmaceutical Co., Ltd. Japan Exchange
Acciones
4555
JP3323050009
Farmacéuticos
Ventas 2024 * | 194 mil M 1241,98 M 1153,35 M | Ventas 2025 * | 203 mil M 1303,92 M 1210,87 M | Capitalización | 254 mil M 1630,54 M 1514,18 M |
---|---|---|---|---|---|
Resultado Neto 2024 * | 19,79 mil M 127 M 118 M | Resultado Neto 2025 * | 19,91 mil M 128 M 119 M | VE / Ventas 2024 * | 1,49 x |
Deuda neta 2024 * | 34,69 mil M 223 M 207 M | Deuda neta 2025 * | 39,72 mil M 255 M 237 M | VE / Ventas 2025 * | 1,45 x |
P/E ratio 2024 * |
12,9
x | P/E ratio 2025 * |
12,7
x | Empleados | 3.393 |
Rendimiento 2024 * |
2,24 % | Rendimiento 2025 * |
2,37 % | Flotante | 0 % |
Directores | Puesto | Edad | Desde |
---|---|---|---|
Mitsuo Sawai
CEO | Chief Executive Officer | 67 | 01/04/21 |
President | 66 | 01/04/21 | |
Toru Terashima
BRD | Director/Board Member | 64 | 01/04/21 |
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Mitsuo Sawai
CEO | Chief Executive Officer | 67 | 01/04/21 |
Kenzo Sawai
BRD | Director/Board Member | 56 | 01/04/21 |
Masatoshi Ohara
BRD | Director/Board Member | 73 | 01/04/21 |
Varia. 1 de ene. | Capi. | |
---|---|---|
+30,38 % | 684 mil M | |
+26,51 % | 568 mil M | |
-4,36 % | 361 mil M | |
+19,30 % | 329 mil M | |
+3,73 % | 284 mil M | |
+16,70 % | 240 mil M | |
+8,78 % | 208 mil M | |
-7,93 % | 200 mil M | |
+7,68 % | 166 mil M |